Interleukin-1 (IL-1) encompasses a family of cytokines, most notably IL-1β, that serve as key mediators of inflammation in both innate and adaptive immunity. Binding of IL-1β to its signalling ...

Interleukin signalling comprises a network of cytokine-mediated pathways that govern immune regulation, tumour cell behaviour and the tumour microenvironment. Key members such as interleukin-4 (IL-4) ...

Sepsis is a complex clinical syndrome characterized by dysregulated immune responses, systemic inflammation, and multi-organ dysfunction. It involves intricate interactions among multiple signaling ...

A recent clinical trial suggests that treating the immune system with an anti-inflammatory drug could relieve symptoms in ...

Key market opportunities lie in developing IL-6 inhibitors for underexplored indications like atherosclerotic cardiovascular disease and thyroid eye disease. The IL-6 targeted therapy market gains ...